KR20210042084A - Hspa8 유전자의 프로모터 - Google Patents

Hspa8 유전자의 프로모터 Download PDF

Info

Publication number
KR20210042084A
KR20210042084A KR1020217002167A KR20217002167A KR20210042084A KR 20210042084 A KR20210042084 A KR 20210042084A KR 1020217002167 A KR1020217002167 A KR 1020217002167A KR 20217002167 A KR20217002167 A KR 20217002167A KR 20210042084 A KR20210042084 A KR 20210042084A
Authority
KR
South Korea
Prior art keywords
nucleotide sequence
hspa8
promoter
polynucleotide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020217002167A
Other languages
English (en)
Korean (ko)
Inventor
겐지 마스다
유토 나카자와
가즈히코 와타나베
마우이 니시오
다케시 오쿠무라
고이치 노나카
Original Assignee
다이이찌 산쿄 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이이찌 산쿄 가부시키가이샤 filed Critical 다이이찌 산쿄 가부시키가이샤
Publication of KR20210042084A publication Critical patent/KR20210042084A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020217002167A 2018-08-09 2019-08-08 Hspa8 유전자의 프로모터 Ceased KR20210042084A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018149854 2018-08-09
JPJP-P-2018-149854 2018-08-09
PCT/JP2019/031295 WO2020032153A1 (ja) 2018-08-09 2019-08-08 Ｈｓｐａ８遺伝子のプロモーター

Publications (1)

Publication Number Publication Date
KR20210042084A true KR20210042084A (ko) 2021-04-16

Family

ID=69415548

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217002167A Ceased KR20210042084A (ko) 2018-08-09 2019-08-08 Hspa8 유전자의 프로모터

Country Status (10)

Country Link
US (1) US20210317498A1 (https=)
EP (1) EP3835423A4 (https=)
JP (1) JPWO2020032153A1 (https=)
KR (1) KR20210042084A (https=)
CN (1) CN112639098A (https=)
AU (1) AU2019318910A1 (https=)
CA (1) CA3109101A1 (https=)
SG (1) SG11202100996TA (https=)
TW (1) TW202020160A (https=)
WO (1) WO2020032153A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202146432A (zh) * 2020-04-03 2021-12-16 日商第一三共股份有限公司 新基因表現單元
WO2023210607A1 (ja) 2022-04-26 2023-11-02 第一三共株式会社 Ｅｎｏ１遺伝子のプロモーター

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3051411U (ja) 1997-04-25 1998-08-25 信一 朝長 安全プラグ
WO2006123097A2 (en) 2005-05-17 2006-11-23 Millipore Corporation Improved expression elements
WO2013080934A1 (ja) 2011-11-28 2013-06-06 第一三共株式会社 ヒト遺伝子由来プロモーター
WO2018066492A1 (ja) 2016-10-03 2018-04-12 第一三共株式会社 Ｈｓｐａ５遺伝子のプロモーター

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056897B2 (en) * 1997-11-03 2006-06-06 The Arizona Board Of Regents Inducible expression vectors and methods of use thereof
EP3093351B1 (en) * 2008-07-09 2018-04-18 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
CA2817256A1 (en) * 2010-11-12 2012-05-18 The General Hospital Corporation Polycomb-associated non-coding rnas
ES3009756T3 (en) * 2013-08-05 2025-03-31 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors, such as lung cancer including nsclc
CN105018528B (zh) * 2015-08-20 2018-04-03 重庆大学 热休克蛋白基因启动子和四环素基因启动子控制的多基因表达和沉默系统

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3051411U (ja) 1997-04-25 1998-08-25 信一 朝長 安全プラグ
WO2006123097A2 (en) 2005-05-17 2006-11-23 Millipore Corporation Improved expression elements
WO2013080934A1 (ja) 2011-11-28 2013-06-06 第一三共株式会社 ヒト遺伝子由来プロモーター
WO2018066492A1 (ja) 2016-10-03 2018-04-12 第一三共株式会社 Ｈｓｐａ５遺伝子のプロモーター

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Boshart M et al., Cell. 41 (2) : 521-530, 1985
Deer JR. and Allison DS., Biotechnol. Prog. 20 : 880-889, 2004
Durocher Y et al., Curr Opin Biotechnol. 20 (6) : 700-707, 2009
Farid SS., J Chromatogr B Analyt Technol Biomed Life Sci. 848 (1) : 8-18, 2007
Florian M. Wurm., Nat. Biotechnol. 22 (11) : 1393-1398, 2004
Foecking MK et al., Gene. 45 (1) : 101-105, 1986
Hoeksema F. et al., Biotechnology Research International, Volume 2011, Article ID 492875, 11 pages
Werner RG. Economic aspects of commercial manufacture of biopharmaceuticals. J Biotechnol. 113 (1-3) : 171-182, 2004

Also Published As

Publication number Publication date
JPWO2020032153A1 (ja) 2021-08-12
EP3835423A4 (en) 2022-08-10
CN112639098A (zh) 2021-04-09
EP3835423A1 (en) 2021-06-16
TW202020160A (zh) 2020-06-01
US20210317498A1 (en) 2021-10-14
WO2020032153A1 (ja) 2020-02-13
CA3109101A1 (en) 2020-02-13
SG11202100996TA (en) 2021-03-30
AU2019318910A1 (en) 2021-02-18

Similar Documents

Publication Publication Date Title
RU2711505C2 (ru) Улучшенные экспрессия и процессинг трансгена
KR20220002609A (ko) 포유동물 세포의 특성을 변경하기 위한 인공 마이크로-rna 및 이들 생성물의 조성물을 사용한 포유동물 세포의 변형
KR20210138587A (ko) 개선된 면역요법을 위한 조합 유전자 표적
KR101476010B1 (ko) 고생산성 세포의 수립을 위한 발현 벡터 및 고생산성 세포
KR20230034198A (ko) 종양 침윤 림프구의 활성화 및 확장 방법
HK1245010A1 (zh) 用於治疗疾病的遗传修饰的细胞、组织和器官
EP0973898A2 (en) SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
KR20140019430A (ko) 염색체 랜딩 패드 및 관련된 용도
KR20120099363A (ko) 탯줄 혈액으로부터의 유도 만능 줄기 세포의 생성
AU2016203681B2 (en) DNA element having the activity of enhancing foreign gene expression
KR20210107057A (ko) 핵산의 표적화 통합
CN111218425A (zh) 人源化转基因动物
CN114277055A (zh) Il1b和il1a基因人源化的非人动物及其构建方法和应用
AU2018204332A1 (en) Expression cassette
CN104066839B (zh) 衍生自人基因的启动子
KR102553990B1 (ko) Hspa5 유전자의 프로모터
KR20210042084A (ko) Hspa8 유전자의 프로모터
RU2744831C2 (ru) Не относящееся к человеку животное, у которого проявляется снижение функции верхних и нижних моторных нейронов и чувственного восприятия
AU2023258798A1 (en) PROMOTER OF Eno1 GENE
KR20230009388A (ko) 인간 게놈 유래 폴리뉴클레오타이드 및 이를 이용한 목적 폴리펩타이드의 생산 방법
WO2021201268A1 (ja) 新規遺伝子発現ユニット

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20210121

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220614

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240930

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20241206

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D